RWE Alliance Submits Comments on FDA's RWE Draft Guidance, Highlights Recommendations for Agency's RWE Program and RWE Derived from EHR/Claims Data

WASHINGTON -- Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration (FDA) draft guidance on using electronic health records (EHRs) and [...]